New CE Webinars on Neonatal Care
Today, more newborns and high-risk neonates have a better chance of thriving because of the advances in medicine and the dedicated care they receive from neonatal nurses on the front line.
Better-Outcomes.org in collaboration with a leading neonatal expert, Dr. Terese Verklan, have developed CE-accredited webinars focusing on neonatal care. These new webinars are available free and on-demand to health professionals involved with the care of our most vulnerable patients.
Unplanned extubation is an unanticipated removal of an endotracheal tube that potentially places a patient at risk for short- or long-term complications. In neonates, spontaneous movement, tube dislodgement during procedures, uncuffed endotracheal tubes, positioning, and suctioning, increase the threat of unplanned extubation in this population. In this CE webinar, neonatal experts will share protocols from their facility on how focusing efforts on controllable measures to reduce the incidence of unplanned extubation in the NICU is crucial to preventing it. Sustaining adherence to prevention measures is the greatest challenge to bedside caregiver and is necessary to protect the patient from harm.
Neonatal hyperbilirubinemia is benign in healthy infants, but can be a significant clinical condition in high-risk babies. This CE activity will discuss the physiology, pathophysiology, etiologies, clinical signs and symptoms and therapeutic management of neonates with conjugated/unconjugated bilirubin.
Advances in neonatal care have led to significant changes in the survival rates of high-risk babies. Positioning and developmental care practices may help to mitigate related complications by promoting positive growth and healing. This CE activity will discuss motor and musculoskeletal development, the use of therapeutic positioning, and positioning to prevent unplanned extubation.
Drug use among pregnant women can lead to problems in the developing fetus including congenital anomalies, problems with growth, preterm labor, withdrawal or toxicity in the newborn, and later problems with neuro-development. One of the most readily apparent problems created by in utero exposure to drugs is neonatal abstinence syndrome. These presentations discuss screening methods to assess the severity of withdrawal signs and the treatment of infants with NAS with both pharmacologic and non-pharmacologic interventions.
Supported by an educational grant from Philips Healthcare
© Saxe Healthcare Communications